New research was presented at TCT 2012—the Transcatheter Cardiovascular Therapeutics annual meeting—from October 22-26 in Miami. The features below highlight just some of the studies that emerged from the conference.

Meeting Highlights

Denervation Treatment Beneficial for Refractory PAH

Dual Antiplatelet Therapy Should Not Be Stopped Withing a Year of PCI

Stenting May Improve Sexual Function in Men

Reducing Cardiovascular Events in Patients with ACS

Managing Atherosclerotic Popliteal Artery Stenosis

Renal Nerve Ablation Achieves Long-Term Blood Pressure Benefits

TAVR Successful in Real-World Setting

Stroke Risk With PCI vs. CABG

PFO Closure Device Superior to Medical Management in Repeat Stroke Prevention

Stent With Mesh Covering Achieves Positive Outcomes

Live Coverage

News Releases for TCT 2012


Registries Demonstrate Positive Long-Term Outcomes with TAVR

Review of TAVR Use Offers Significant Advances, Positive Outcomes

Registries Show Low Complication Rates with New Heart Valves

PCI Associated with Lower Stroke Risk than CABG

Globalization of Innovation a “Must Have” to Improve Healthcare Delivery

DES: The Year in Review

New Results from SYNTAX, SPIRIT Trials Presented

Second-Generation DES Safer, More Effective than BMS in STEMI at 1 Year

SYNTAX: DES, CABG Comparable in Left Main Disease

COURAGE, FAME: Revascularization More Effective than OMT

Several Trials Highlight DES Comparisons

Meta-Analyses Show Improved Outcomes with DES vs. BMS


HARVi 1.0 iPad App Explains Fundamentals of Hemodynamics

Pre-PCI Statin Regimen Produces No Significant Effect on Troponin I Release

DEBATE-SFA Favors Predilatation with Drug-Eluting Balloon Before BMS

Repositionable Valves Found Safe, Effective in Two Trials

Successful Device Innovation Focuses on Clinical Needs, Multidisciplinary Approach

Large Study Finds Comparable 8-Month TVF for PES, SES

TAVI Pipeline Promising

PFO Closure Back in the Spotlight


Novel Devices Provide Options for LAA Therapy

ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD

Mesh-Covered Stent Shines in MASTER Trial

Presentations Examine Multiple Facets of Antiplatelet Agents

Maintaining Successful Practice Depends on Changing Old Habits, Embracing CV Services Lines

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

FAME 2: FFR-Guided PCI Coste Effective vs. Medical Therapy


Centrifugal Pump Feasible Treatment for Refractory RV Failure

Extended EVEREST II Data Examine Safety, Efficacy of MitraClip as Well as Cost Effectiveness

Positive Results Seen with Angioplasty for Critical Hand Ischemia

Transradial PCI Reduces Bleeding in High-Risk ACS Patients

Day 5

Paclitaxel-Eluting Balloons, Stents Best Angioplasty in Treatment of Restenosis

Radial PCI Bests Femoral in STEMI Patients

More from TCT 2012

Slide Presentations

Live Case Sites

TCTMD Mobile App

TCTMD Connect professional networking site

TCTMD Gold and Prime Premium Subscriptions

Virtual TCT

Special Activities

TCT Week at a Glance

About TCT

Complete Agenda

Final Program

Sessions by Specialty

Integrated Course for Surgeons

Endovascular Course

Board Review Course with Self-Assessment

ABCs of Interventional Cardiology

Heart Team Approach at TCT

Satellite Symposia

Edited Taped Cases